| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Gene, HNF3
(FOXA1), on Chromosome Band 14q13 Is Amplified and Overexpressed in Esophageal and Lung Adenocarcinomas1
Section of General Thoracic Surgery, Departments of Surgery [L. L., C. T. M., J. I. C., M. S. P., J. Y., M. B. O., D. G. B.], Human Genetics [S. L. D., T. W. G.], Pathology [R. W.], and Pediatrics [D. E. M., S. M. H., T. W. G.], University of Michigan Medical School, Ann Arbor, Michigan 48109
Genomic amplification is observed in many, if not all, types of human malignancy and is one of the mechanisms for the activation of dominant-acting oncogenes in tumorigenesis. In the present study, three amplified restriction fragments were identified in an esophageal adenocarcinoma (P16) using the restriction landmark genome scanning two-dimensional gel technique. These fragments were cloned, sequenced, and mapped to chromosome band 14q13. Using the sequence tagged site-amplification mapping approach, we defined the core-amplified domain by screening 75 normal-tumor paired esophageal samples. The frequency of 14q13 amplification is 6.7% in esophageal tumors, and the amplicon spans >6 Mb in 1 tumor but is contained in a region <0.3 Mb in all of the remaining amplified tumors. Quantitative reverse transcription-PCR (RT-PCR) of 8 genes and expressed sequence tags located within the core-amplified domain revealed that the HNF3
(FOXA1)4
gene, a forkhead gene family member, was overexpressed in all of the amplified esophageal tumors. HNF3
amplification was confirmed by Southern blot and interphase fluorescence in situ hybridization analyses, and the results of real-time RT-PCR were consistent with that of the regular quantitative RT-PCR. Increased immunohistochemical nuclear staining of the HNF3
protein was detected in all of the tumors containing 14q13 amplification. Affymetrix oligonucleotide microarrays of 86 lung adenocarcinomas demonstrated that expression of the HNF3
mRNA was elevated (
2.5-fold of mean expression in normal lung) in 37% (32 of 86) of the tumors analyzed. Gene amplification of HNF3
was detected in 2 of the 5 overexpressed lung tumors examined. This is the first report of HNF3
amplification, and overexpression in esophageal and lung adenocarcinomas. Amplification of HNF3
in esophageal and lung tumors may suggest a potential oncogenic role for this gene in tumorigenesis.
This article has been cited by other articles:
![]() |
C. Nucera, J. Eeckhoute, S. Finn, J. S. Carroll, A. H. Ligon, C. Priolo, G. Fadda, M. Toner, O. Sheils, M. Attard, et al. FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma Clin. Cancer Res., June 1, 2009; 15(11): 3680 - 3689. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jonckheere, A. Vincent, M. Perrais, M.-P. Ducourouble, A. K.-v. Male, J.-P. Aubert, P. Pigny, K. L. Carraway, J.-N. Freund, I. B. Renes, et al. The Human Mucin MUC4 Is Transcriptionally Regulated by Caudal-related Homeobox, Hepatocyte Nuclear Factors, Forkhead Box A, and GATA Endodermal Transcription Factors in Epithelial Cancer Cells J. Biol. Chem., August 3, 2007; 282(31): 22638 - 22650. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Sagaert, P. de Paepe, L. Libbrecht, V. Vanhentenrijk, G. Verhoef, J. Thomas, I. Wlodarska, and C. De Wolf-Peeters Forkhead Box Protein P1 Expression in Mucosa-Associated Lymphoid Tissue Lymphomas Predicts Poor Prognosis and Transformation to Diffuse Large B-Cell Lymphoma J. Clin. Oncol., June 1, 2006; 24(16): 2490 - 2497. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wan, S. Dingle, Y. Xu, V. Besnard, K. H. Kaestner, S.-L. Ang, S. Wert, M. T. Stahlman, and J. A. Whitsett Compensatory Roles of Foxa1 and Foxa2 during Lung Morphogenesis J. Biol. Chem., April 8, 2005; 280(14): 13809 - 13816. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kauraniemi, T. Kuukasjarvi, G. Sauter, and A. Kallioniemi Amplification of a 280-Kilobase Core Region at the ERBB2 Locus Leads to Activation of Two Hypothetical Proteins in Breast Cancer Am. J. Pathol., November 1, 2003; 163(5): 1979 - 1984. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Miller, J. R. Moy, L. Lin, M. Schipper, D. Normolle, D. E. Brenner, M. D. Iannettoni, M. B. Orringer, and D. G. Beer Gene Amplification in Esophageal Adenocarcinomas and Barrett's with High-Grade Dysplasia Clin. Cancer Res., October 15, 2003; 9(13): 4819 - 4825. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |